PLAU and breast cancer: To determine whether this interaction occurs at the surface of MDA-MB-231 cells (a breast cancer cell line that has high endogenous uPA expression [27]), binding experiments using antibodies directed against the A- or B-chain of uPA were performed under conditions that predominantly exclude proteolytic activation of plg by uPA.